Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

440 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
MRI-based radiomic prognostic signature for locally advanced oral cavity squamous cell carcinoma: development, testing and comparison with genomic prognostic signatures.
Corti A, De Cecco L, Cavalieri S, Lenoci D, Pistore F, Calareso G, Mattavelli D, de Graaf P, Leemans CR, Brakenhoff RH, Ravanelli M, Poli T, Licitra L, Corino V, Mainardi L. Corti A, et al. Among authors: licitra l. Biomark Res. 2023 Jul 16;11(1):69. doi: 10.1186/s40364-023-00494-5. Biomark Res. 2023. PMID: 37455307 Free PMC article.
Functional Genomics Uncover the Biology behind the Responsiveness of Head and Neck Squamous Cell Cancer Patients to Cetuximab.
Bossi P, Bergamini C, Siano M, Cossu Rocca M, Sponghini AP, Favales F, Giannoccaro M, Marchesi E, Cortelazzi B, Perrone F, Pilotti S, Locati LD, Licitra L, Canevari S, De Cecco L. Bossi P, et al. Among authors: licitra l. Clin Cancer Res. 2016 Aug 1;22(15):3961-70. doi: 10.1158/1078-0432.CCR-15-2547. Epub 2016 Feb 26. Clin Cancer Res. 2016. PMID: 26920888
Are Fusion Transcripts in Relapsed/Metastatic Head and Neck Cancer Patients Predictive of Response to Anti-EGFR Therapies?
Bossi P, Siano M, Bergamini C, Cossu Rocca M, Sponghini AP, Giannoccaro M, Tonella L, Paoli A, Marchesi E, Perrone F, Pilotti S, Locati LD, Canevari S, Licitra L, De Cecco L. Bossi P, et al. Among authors: licitra l. Dis Markers. 2017;2017:6870614. doi: 10.1155/2017/6870614. Epub 2017 Nov 12. Dis Markers. 2017. PMID: 29259349 Free PMC article.
Circulating miR-375 as a novel prognostic marker for metastatic medullary thyroid cancer patients.
Romeo P, Colombo C, Granata R, Calareso G, Gualeni AV, Dugo M, De Cecco L, Rizzetti MG, Zanframundo A, Aiello A, Carcangiu ML, Gloghini A, Ferrero S, Licitra L, Greco A, Fugazzola L, Locati LD, Borrello MG. Romeo P, et al. Among authors: licitra l. Endocr Relat Cancer. 2018 Mar;25(3):217-231. doi: 10.1530/ERC-17-0389. Epub 2018 Jan 3. Endocr Relat Cancer. 2018. PMID: 29298817 Free article. Clinical Trial.
Activity and safety of afatinib in a window preoperative EORTC study in patients with squamous cell carcinoma of the head and neck (SCCHN).
Machiels JP, Bossi P, Menis J, Lia M, Fortpied C, Liu Y, Lhommel R, Lemort M, Schmitz S, Canevari S, De Cecco L, Guzzo M, Bianchi R, Quattrone P, Crippa F, Duprez T, Lalami Y, Quiriny M, de Saint Aubain N, Clement PM, Coropciuc R, Hauben E, Licitra LF. Machiels JP, et al. Among authors: licitra lf. Ann Oncol. 2018 Apr 1;29(4):985-991. doi: 10.1093/annonc/mdy013. Ann Oncol. 2018. PMID: 29346507 Free article. Clinical Trial.
Immunotherapy for recurrent/metastatic head and neck cancer.
Alfieri S, Cavalieri S, Licitra L. Alfieri S, et al. Among authors: licitra l. Curr Opin Otolaryngol Head Neck Surg. 2018 Apr;26(2):152-156. doi: 10.1097/MOO.0000000000000448. Curr Opin Otolaryngol Head Neck Surg. 2018. PMID: 29432222 Review.
Lenvatinib-induced renal failure: two first-time case reports and review of literature.
Cavalieri S, Cosmai L, Genderini A, Nebuloni M, Tosoni A, Favales F, Pistillo P, Bergamini C, Bossi P, Licitra L, Locati LD, Alfieri S. Cavalieri S, et al. Among authors: licitra l. Expert Opin Drug Metab Toxicol. 2018 Apr;14(4):379-385. doi: 10.1080/17425255.2018.1461839. Epub 2018 Apr 13. Expert Opin Drug Metab Toxicol. 2018. PMID: 29617171 Free article. Review.
440 results